Immutep
IMMP
#10119
Rank
C$82.14 M
Marketcap
C$0.56
Share price
3.16%
Change (1 day)
-77.45%
Change (1 year)

Earnings for Immutep (IMMP)

Earnings in 2024: -C$40.19 Million

According to Immutep's latest financial reports the company's current earnings are -C$0.01 Million. In 2024 the company made an earning of -C$40.19 Million a decrease over its 2023 earnings that were of -C$37.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immutep from 2008 to 2024

Annual earnings

Year Earnings Change
2024-C$40.19 Million7.23%
2023-C$37.49 Million19.67%
2022-C$31.33 Million-0.9%
2021-C$31.61 Million141.19%
2020-C$13.11 Million-27.85%
2019-C$18.17 Million36.56%
2018-C$13.31 Million21.61%
2017-C$10.94 Million-83.52%
2016-C$66.37 Million89.45%
2015-C$35.03 Million97.68%
2014-C$17.72 Million-9.05%
2013-C$19.49 Million-32.33%
2012-C$28.8 Million-9.61%
2011-C$31.86 Million48.52%
2010-C$21.45 Million538.22%
2009-C$3.37 Million32.05%
2008-C$2.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Illumina
ILMN
C$1.63 B-12,717.39%๐Ÿ‡บ๐Ÿ‡ธ USA
FibroGen
FGEN
-C$0.19 Billion 1,298.90%๐Ÿ‡บ๐Ÿ‡ธ USA
HTG Molecular Diagnostics
HTGM
-C$27.53 Million 112.36%๐Ÿ‡บ๐Ÿ‡ธ USA